Lakewood Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
37,194
+164
| +0.4% | +$7.59K | 1.15% | 29 |
|
|
2025
Q1 | $2.26M | Buy |
37,030
+10,163
| +38% | +$620K | 1.52% | 21 |
|
|
2024
Q4 | $1.52M | Buy |
26,867
+195
| +0.7% | +$11K | 1.05% | 28 |
|
|
2024
Q3 | $1.38M | Sell |
26,672
-2,286
| -8% | -$118K | 0.94% | 32 |
|
|
2024
Q2 | $1.2M | Sell |
28,958
-135
| -0.5% | -$5.61K | 0.84% | 33 |
|
|
2024
Q1 | $1.58M | Buy |
29,093
+2,744
| +10% | +$149K | 1.07% | 31 |
|
|
2023
Q4 | $1.35M | Sell |
26,349
-5,765
| -18% | -$296K | 1.05% | 29 |
|
|
2023
Q3 | $1.86M | Sell |
32,114
-546
| -2% | -$31.7K | 1.52% | 19 |
|
|
2023
Q2 | $2.09M | Buy |
32,660
+499
| +2% | +$31.9K | 1.64% | 14 |
|
|
2023
Q1 | $2.23M | Buy |
32,161
+365
| +1% | +$25.3K | 1.85% | 14 |
|
|
2022
Q4 | $2.29M | Buy |
+31,796
| New | +$2.29M | 1.85% | 10 |
|